Oncosil Medical Ltd
ASX:OSL
Oncosil Medical Ltd
Income from Continuing Operations
Oncosil Medical Ltd
Income from Continuing Operations Peer Comparison
Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors
Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Oncosil Medical Ltd
ASX:OSL
|
Income from Continuing Operations
-AU$11.7m
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-16%
|
|
Anteotech Ltd
ASX:ADO
|
Income from Continuing Operations
-AU$11.5m
|
CAGR 3-Years
-49%
|
CAGR 5-Years
-39%
|
CAGR 10-Years
-19%
|
|
Proteomics International Laboratories Ltd
ASX:PIQ
|
Income from Continuing Operations
-AU$6m
|
CAGR 3-Years
-36%
|
CAGR 5-Years
-26%
|
CAGR 10-Years
N/A
|
|
Cryosite Ltd
ASX:CTE
|
Income from Continuing Operations
AU$1.6m
|
CAGR 3-Years
45%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
4%
|
|
Genetic Signatures Ltd
ASX:GSS
|
Income from Continuing Operations
-AU$18m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-40%
|
CAGR 10-Years
N/A
|
|
E
|
EZZ Life Science Holdings Ltd
ASX:EZZ
|
Income from Continuing Operations
AU$3.6m
|
CAGR 3-Years
32%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Oncosil Medical Ltd's Income from Continuing Operations?
Income from Continuing Operations
-11.7m
AUD
Based on the financial report for Dec 31, 2023, Oncosil Medical Ltd's Income from Continuing Operations amounts to -11.7m AUD.
What is Oncosil Medical Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
-16%
Over the last year, the Income from Continuing Operations growth was -10%. The average annual Income from Continuing Operations growth rates for Oncosil Medical Ltd have been -28% over the past three years , -5% over the past five years , and -16% over the past ten years .